Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07594769
PHASE1

A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults

Sponsor: Pfizer

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the bioequivalence of an alternative ODT formulation (ODT2) versus the approved ODT formulation of a CGRP receptor antagonist in healthy adult participants under fasting conditions.

Official title: A PHASE 1, OPEN LABEL, SINGLE DOSE, RANDOMIZED, CROSSOVER STUDY TO EVALUATE THE BIOEQUIVALENCE OF TWO FORMULATIONS OF A CGRP RECEPTOR ANTAGONIST IN HEALTHY ADULT PARTICIPANTS

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2026-05-18

Completion Date

2026-09-07

Last Updated

2026-05-22

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

ODT2 Test formulation

Test Formulation

DRUG

ODT Reference formulation

Reference Formulation

Locations (1)

Pfizer Clinical Research Unit - Brussels

Brussels, Bruxelles-capitale, Région de, Belgium